Raia Drogasil (OTCMKTS:RADLY) Hits New 12-Month Low - Time to Sell?

Key Points

• Raia Drogasil shares fell to a new 52-week low, reaching $2.88 and last trading at $2.9480 versus a prior close of $4.16.
• Despite the decline, Jefferies upgraded the stock to “Buy” with a $5.20 price target. Analysts’ consensus is “Moderate Buy,” based on one Buy and one Hold rating.
• The company met quarterly EPS expectations at $0.05, but revenue of $2.17 billion came in below the $2.32 billion analyst forecast; analysts expect full-year EPS of approximately $0.17.

Raia Drogasil S.A. (OTCMKTS:RADLY - Get Free Report) shares hit a new 52-week low during trading on Monday. The company traded as low as $2.88 and last traded at $2.9480, with a volume of 2,068 shares traded. The stock had previously closed at $4.16.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group upgraded shares of Raia Drogasil to a "buy" rating and set a $5.20 target price for the company in a research report on Sunday, October 18th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $5.20.

Raia Drogasil Stock Performance

The firm has a market cap of $3.95 billion and a PE ratio of 20.00. The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.58 and a current ratio of 1.41. The firm's 50 day moving average price is $3.81 and its two-hundred day moving average price is $3.84.

Raia Drogasil (OTCMKTS:RADLY - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, hitting analysts' consensus estimates of $0.05. The company had revenue of $2.17 billion for the quarter, compared to analysts' expectations of $2.32 billion. Raia Drogasil had a return on equity of 20.12% and a net margin of 2.99%. On average, research analysts forecast that Raia Drogasil S.A. will post 0.17 earnings per share for the current year.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.